State Of Wyoming Passage Bio, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.66 - $6.49 $15 - $38	-6 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$6.24 - $10.2 $6 - $10	-1 Reduced 14.29%	6 $0
Q3 2021 Feb 11, 2022	SELL	$9.73 - $15.52 $126 - $201	-13 Reduced 65.0%	7 $0
Q2 2021 Feb 11, 2022	BUY	$12.44 - $19.45 $136 - $213	11 Added 122.22%	20 $0
Q1 2021 Feb 08, 2022	BUY	$16.24 - $29.83 $146 - $268	9 New	9 $0

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $39.2M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.